JPH0339087A - Lyophilized medium and bag containing same medium - Google Patents
Lyophilized medium and bag containing same mediumInfo
- Publication number
- JPH0339087A JPH0339087A JP1172721A JP17272189A JPH0339087A JP H0339087 A JPH0339087 A JP H0339087A JP 1172721 A JP1172721 A JP 1172721A JP 17272189 A JP17272189 A JP 17272189A JP H0339087 A JPH0339087 A JP H0339087A
- Authority
- JP
- Japan
- Prior art keywords
- medium
- lyophilized
- bag
- components
- main body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002904 solvent Substances 0.000 claims abstract description 9
- 150000001413 amino acids Chemical class 0.000 claims abstract description 6
- 229940088594 vitamin Drugs 0.000 claims abstract description 6
- 235000013343 vitamin Nutrition 0.000 claims abstract description 6
- 239000011782 vitamin Substances 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 6
- 229910017053 inorganic salt Inorganic materials 0.000 claims abstract description 5
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 5
- 229920003002 synthetic resin Polymers 0.000 claims abstract description 3
- 239000000057 synthetic resin Substances 0.000 claims abstract description 3
- 239000002609 medium Substances 0.000 claims description 47
- 239000001963 growth medium Substances 0.000 claims description 22
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 7
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 238000004108 freeze drying Methods 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 15
- 239000007788 liquid Substances 0.000 abstract description 13
- 239000012153 distilled water Substances 0.000 abstract description 7
- 229940024606 amino acid Drugs 0.000 abstract description 5
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 abstract description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 abstract description 4
- 230000001012 protector Effects 0.000 abstract description 4
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 abstract description 2
- 235000019743 Choline chloride Nutrition 0.000 abstract description 2
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract description 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 abstract description 2
- 229960003767 alanine Drugs 0.000 abstract description 2
- 229960002685 biotin Drugs 0.000 abstract description 2
- 235000020958 biotin Nutrition 0.000 abstract description 2
- 239000011616 biotin Substances 0.000 abstract description 2
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 abstract description 2
- 229960003178 choline chloride Drugs 0.000 abstract description 2
- 229920000728 polyester Polymers 0.000 abstract description 2
- 239000000843 powder Substances 0.000 abstract description 2
- 239000011780 sodium chloride Substances 0.000 abstract description 2
- WRUGWIBCXHJTDG-UHFFFAOYSA-L magnesium sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Mg+2].[O-]S([O-])(=O)=O WRUGWIBCXHJTDG-UHFFFAOYSA-L 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 239000008223 sterile water Substances 0.000 abstract 1
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 3
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- -1 L-cystine lactate Chemical compound 0.000 description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 239000012679 serum free medium Substances 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- RRBYELIZBDUICD-FIJGZFCASA-N (2r)-2-amino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid;(2s)-2-aminopentanedioic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O.OC(=O)[C@@H](N)CSSC[C@H](N)C(O)=O RRBYELIZBDUICD-FIJGZFCASA-N 0.000 description 1
- IOCJWNPYGRVHLN-MMALYQPHSA-N (2r)-2-amino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid;hydrochloride Chemical compound Cl.OC(=O)[C@@H](N)CSSC[C@H](N)C(O)=O IOCJWNPYGRVHLN-MMALYQPHSA-N 0.000 description 1
- BDZKNNGXQCRJAZ-MMALYQPHSA-N (2r)-2-amino-3-[[(2r)-2-amino-2-carboxyethyl]disulfanyl]propanoic acid;sodium Chemical compound [Na].OC(=O)[C@@H](N)CSSC[C@H](N)C(O)=O BDZKNNGXQCRJAZ-MMALYQPHSA-N 0.000 description 1
- QZNNVYOVQUKYSC-JEDNCBNOSA-N (2s)-2-amino-3-(1h-imidazol-5-yl)propanoic acid;hydron;chloride Chemical compound Cl.OC(=O)[C@@H](N)CC1=CN=CN1 QZNNVYOVQUKYSC-JEDNCBNOSA-N 0.000 description 1
- RPLOMRKIYCIKRV-QRPNPIFTSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;sodium Chemical compound [Na].OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 RPLOMRKIYCIKRV-QRPNPIFTSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- KWTQSFXGGICVPE-UHFFFAOYSA-N 2-amino-5-(diaminomethylideneamino)pentanoic acid;hydron;chloride Chemical compound Cl.OC(=O)C(N)CCCN=C(N)N KWTQSFXGGICVPE-UHFFFAOYSA-N 0.000 description 1
- 102000009027 Albumins Human genes 0.000 description 1
- 108010088751 Albumins Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 description 1
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- CKLJMWTZIZZHCS-UWTATZPHSA-N L-Aspartic acid Natural products OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 description 1
- 229930064664 L-arginine Natural products 0.000 description 1
- 235000014852 L-arginine Nutrition 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- 239000004158 L-cystine Substances 0.000 description 1
- 235000019393 L-cystine Nutrition 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- BVHLGVCQOALMSV-JEDNCBNOSA-N L-lysine hydrochloride Chemical compound Cl.NCCCC[C@H](N)C(O)=O BVHLGVCQOALMSV-JEDNCBNOSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- JUIUXBHZFNHITF-IEOSBIPESA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] dihydrogen phosphate Chemical compound OP(=O)(O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C JUIUXBHZFNHITF-IEOSBIPESA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 210000004102 animal cell Anatomy 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- FYPVXEILSNEKOO-UHFFFAOYSA-L calcium;butanoate Chemical compound [Ca+2].CCCC([O-])=O.CCCC([O-])=O FYPVXEILSNEKOO-UHFFFAOYSA-L 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- QWJSAWXRUVVRLH-UHFFFAOYSA-M choline bitartrate Chemical compound C[N+](C)(C)CCO.OC(=O)C(O)C(O)C([O-])=O QWJSAWXRUVVRLH-UHFFFAOYSA-M 0.000 description 1
- 229960004874 choline bitartrate Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- RZXDTJIXPSCHCI-UHFFFAOYSA-N hexa-1,5-diene-2,5-diol Chemical compound OC(=C)CCC(O)=C RZXDTJIXPSCHCI-UHFFFAOYSA-N 0.000 description 1
- 229960002885 histidine Drugs 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N inositol Chemical compound OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229960003136 leucine Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 229960005190 phenylalanine Drugs 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000131 polyvinylidene Polymers 0.000 description 1
- 239000005033 polyvinylidene chloride Substances 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229960001153 serine Drugs 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940083542 sodium Drugs 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- WPLOVIFNBMNBPD-ATHMIXSHSA-N subtilin Chemical compound CC1SCC(NC2=O)C(=O)NC(CC(N)=O)C(=O)NC(C(=O)NC(CCCCN)C(=O)NC(C(C)CC)C(=O)NC(=C)C(=O)NC(CCCCN)C(O)=O)CSC(C)C2NC(=O)C(CC(C)C)NC(=O)C1NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C1NC(=O)C(=C/C)/NC(=O)C(CCC(N)=O)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)CNC(=O)C(NC(=O)C(NC(=O)C2NC(=O)CNC(=O)C3CCCN3C(=O)C(NC(=O)C3NC(=O)C(CC(C)C)NC(=O)C(=C)NC(=O)C(CCC(O)=O)NC(=O)C(NC(=O)C(CCCCN)NC(=O)C(N)CC=4C5=CC=CC=C5NC=4)CSC3)C(C)SC2)C(C)C)C(C)SC1)CC1=CC=CC=C1 WPLOVIFNBMNBPD-ATHMIXSHSA-N 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
- 229960004441 tyrosine Drugs 0.000 description 1
- 229960004295 valine Drugs 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
〔産業上の利用分野〕
本発明は、一般に培養を行う際に使用される培地と培地
入りバッグであって、研究用、工業生産用を問わず、細
胞、微生物等の培養を行う際に使用されるもので、特に
、凍結乾燥された培地と該培地を封入した培地入りバッ
グに関するものである。[Industrial Application Field] The present invention relates to a culture medium and a bag containing the culture medium that are generally used for culturing, and are suitable for culturing cells, microorganisms, etc., whether for research or industrial production. In particular, it relates to a freeze-dried medium and a bag containing the medium.
動物性細胞を培養する際に、これら細胞に栄養を付与す
るため培地が使用されるが、これらの培地はアミノ酸、
ビタミン、無機塩類等の種々の試薬を混合して作成され
1通常、液体あるいは固体の粉末の状態で市販されてい
る。
しかしながら、これら液体状の培地と粉末状の培地は次
のような不都合な点があった。
粉末培地の場合は、使用の際に、その所定量を所定量の
水に溶解して水溶液として、所定の抗生物質を該水溶液
に添加して、培地を調整してから、滅菌用フィルターを
介して培養容器へ移送して使用していた。
しかしながら、これらの培地は、水に溶けにくいため調
整に手間がかかり、また滅菌フィルターを介して培養容
器に導入しなければならないので、培養容器への導入の
手間が煩わしかった。
液体培地の場合は、前述のように粉末培地を水に溶解し
て調整し、所定の滅菌処理を施して。
タンク等に所定期間貯留したものを必要な分だけ培養容
器に導入して使用するものである。
しかし液体培地は、長期間貯留するとPHが変化して細
胞の培養に使用できなくなる欠点があった。
また保存する際、大型のタンクに保存するので、重くて
持ち運びが不便であった。
そこで本発明者は、以上の課題を解決するために、鋭意
検討を重ねた結果、培地を凍結乾燥処理することにより
、調整が容易で長期に亘って保存できる培地を発明する
ことに成功した。
さらに、該凍結乾燥培地を可撓性のバッグに封入するこ
とにより、より良い培地入り容器を提供することに成功
した。
[課題を解決するための手段]
本発明の培地は、少なくとも1種類以上のアミノ酸成分
と、少むくと61種類以上のビタミン成分と、少なくと
ち1種類以上の無機塩類成分からなる蛋白成分を含有し
た無血清培地を真空下で凍結乾燥することにより得られ
る培地である。
アミノ酸の成分としては、L−アラニン、L−アルギニ
ン、L−塩酸アルギニン、L−シスチン、L−塩酸シス
チン、L−シスチン−垣酸塩(l水イヒ、物)、L−シ
スチンナトリウム、L−グルタミン酸、L−ヒスチジン
、L−ヒスチジン−塩酸塩(1水化物)、L−インロイ
シン、L−ロイシン、L−リジン、L−塩酸リジン、L
−メチオニン、L−フェニルアラニン。
L−スレオニン、L−トリプトファン、L−チロシン、
L−チロシンナトリウム、L−バリン、L−アスパラギ
ン酸、L−アスコルビン酸、L−セリン、L−プロリン
等の中から数種のものが使用され、ビタミン成分として
は、ビオチン、塩化コリン、コリンニ酒石酸、葉酸、D
−パントテン酸カルシウム、イソイノシトール、ニコチ
ンアミド、塩酸ピリドキシン、リボフラビン、塩酸チア
ミン、a−トコフェロールリン酸ナトリウム、ビタミン
B口、バラアミノ安息香酸等の中から数種のものが使用
され、無機塩類成分として、塩化カリウム、炭酸水素ナ
トリウム、塩化ナトリウム、無水塩化カルシウム、無水
塩化マグネシウム。
無水硫酸マグネシウム、
無水リン酸二水素ナトリウム
リン酸−水素ナトリウム・7水fNaJPO44)IJ
Iリン酸二水素ナトリウム・l水(NaHtPO4・H
2O)硫酸マグネシウム・7水(MgSO,・7H,0
1リン酸二水素カリウム
等の中から少なくとち1種以上が使用され、上記以外の
成分として、酪酸カルシウム、D−グルコース、フェノ
ールレッド、酢酸ナトリウム、コハク酸、HEPES、
アルブミンなどが使用される。
凍結乾燥培地の製造方法は次の如くである。
第1段階として、所定量の場末培地を所定量の無薗水に
溶解して、所定量の液体培地にする。
第2段階として、所定量の液体培地を所定容量の容器に
入れて、該容器を真空凍結乾燥機の凍結槽内で、液体培
地を凍結させる。
第3段階として、真空凍結乾燥機に前記容器を接続して
、所定時間乾燥させる。
以上のようにして、得られた凍結乾燥培地は第1図に示
す培地入りバッグに封入して使用される。
培地入りバッグ1は1例えばエチレン−ビニルアルコー
ル、ポリ塩化ビニリデン、ポリアミド、ポリエステル、
アクリロニトリループシタジエンラバー(NBR)にア
クリロニトリル(AN)とメチルアクリレート(MA)
をグラフト共重合させたちの(商品名;バレックス)可
塑剤を含まない軟質ポリ塩化ビニル(商品名:エスメデ
ィカV)、(商品名、ゼクロン)等よりなるガス不透過
性可撓性合成樹脂性の袋状本体2と該本体2の上端部に
接続されている蒸留水等の溶媒注入チューブ3とプロテ
クター8で覆われた培地導出口4より構成される。
溶媒注入チューブ3の先端には、蒸留水等の溶媒入り容
器との接続針5が形成され、途中には、除菌フィルター
6とクランプ7が配置されている。
除菌フィルターの材質は、ポリビニリデン2−フロライ
ド、ポリテトラフロロエチレン、セルロースエステル等
が使用でき、又孔径は0.22μの物が菌の侵入を防ぐ
ことができる。
さらに本体2の内部には、前述した凍結乾燥培地9が封
入されている。
これらの凍結乾燥培地9を本体2内部に封入する方法と
しては1袋状本体2をシート又は押し出し成形チューブ
により袋状にシールして形成する際に封入しても良いし
、あるいは、袋状に形成した後、油媒の注入用チューブ
3を袋状本体2に接続する前に、接続部付近から本体2
内に培地を導入しても良い。
あるいは、凍結乾燥培地を所定量の溶媒に溶解して液体
培地とし、これを培地バッグ内に封入するようにしても
良い。
そして、これらの培地入りバッグ1は使用前に放射線滅
菌、EOG滅菌等を施し、無菌状態にしておいてから使
用される。
[実施例]
藍胤廻ユ
凍結乾燥培地の製造方法を以下に説明
する。
シグマ社製の粉末RPMI 1640培地10.4gと
炭酸水素ナトリウム2gを10分間かけて無薗水に溶解
して1βの液体培地とした。
次に、前記液体培地100m12を500m!2の容器
に入れて、該容器を真空凍結乾燥機(東京理化器機製、
FD−1型)の凍結槽中に入れて、前記培地が、容器の
壁面に凍結するまで15分間凍結させた。
さらに、前記容器を、真空凍結乾燥機の真空ラインに接
続して、真空度76 +nmHg、冷却温度−45℃で
、22時間乾燥を行った。
乾燥後、多孔質固体の凍結乾燥培地が得られた。
これらの凍結乾燥培地と前記粉末PRMII640培地
を同量採取し、同量の水溶液に溶解して溶解速度を目視
で比較したところ、凍結乾燥培地の方が、速やかに水溶
液に溶解することが確認できた。
これは、凍結乾燥培地は、多孔質固体であるから前記粉
末培地よりも表面積が増大しているためと考えられる。
尖1u糺ヱ
本発明の培地入りバッグエを使用して、培地を調整する
方法は次の通りである。
培地入りバッグ1の接続針5を、蒸留水入りプラスチッ
クボトル10の口部に接続して、重力による落差より培
地チューブ3を経て本体2内に蒸留水を注入する。
蒸留水内に存在している菌は、除菌フィルター6により
補足されて、本体2内に混入するおそれがない。
注入用チューブ3を本体2の上端部付近でシールして切
断した後、本体2を良く撹拌して培地を蒸留水に溶解し
て所定の培地を調整する。
この培地を使用する際には、プロテクター8を破断して
、培地導出口4を露出し、これに連結チューブ12の一
端に、装着された連通針11を接続して、連結チューブ
12の他方の一端に接続された連結針11を、培養バッ
グ13(または培養細胞を封入した半透1i15を有す
る濃縮培養バッグ13a)の培地導入口14(または1
4a)に接続して、連通チューブ12を経て、培地を培
養バッグ13〔または濃縮培養バッグ13a)に導出し
培養を行うちのである。
[発明の効果]
以上説明したように
■本発明の凍結乾燥培地は、溶媒に溶解しやすく液体培
地の調整が容易である。
■凍結乾燥培地を封入した培地入りバッグは、滅菌が行
いやすく、長期保存性、大量保管性。
輸送性に優れるものである。
等の効果を有する優れた発明である。When culturing animal cells, media are used to provide nutrients to these cells, and these media contain amino acids,
It is prepared by mixing various reagents such as vitamins and inorganic salts, and is usually commercially available in the form of liquid or solid powder. However, these liquid media and powdered media have the following disadvantages. In the case of a powdered medium, when using it, dissolve a predetermined amount in a predetermined amount of water to make an aqueous solution, add a predetermined antibiotic to the aqueous solution, adjust the medium, and then pass it through a sterilization filter. The cells were then transferred to a culture container for use. However, since these media are difficult to dissolve in water, it takes time and effort to prepare them, and since they must be introduced into the culture container through a sterilization filter, it is troublesome to introduce them into the culture container. In the case of a liquid medium, prepare the powdered medium by dissolving it in water as described above, and then perform the prescribed sterilization process. It is stored in a tank or the like for a predetermined period of time and used by introducing the required amount into a culture container. However, liquid media have the disadvantage that when stored for a long period of time, the pH changes, making them unusable for cell culture. Also, when storing it, it is stored in a large tank, which is heavy and inconvenient to carry. In order to solve the above problems, the inventors of the present invention conducted extensive studies and succeeded in inventing a medium that is easy to adjust and can be stored for a long period of time by freeze-drying the medium. Furthermore, by enclosing the freeze-dried medium in a flexible bag, we succeeded in providing a better medium-containing container. [Means for Solving the Problems] The culture medium of the present invention contains a protein component consisting of at least one type of amino acid component, at least 61 types of vitamin components, and at least one type of inorganic salt component. This is a medium obtained by freeze-drying a serum-free medium containing the serum-free medium under vacuum. Amino acid components include L-alanine, L-arginine, L-arginine hydrochloride, L-cystine, L-cystine hydrochloride, L-cystine lactate (l-hydrochloride, mono), L-cystine sodium, L-cystine Glutamic acid, L-histidine, L-histidine hydrochloride (monohydrate), L-inleucine, L-leucine, L-lysine, L-lysine hydrochloride, L
-Methionine, L-phenylalanine. L-threonine, L-tryptophan, L-tyrosine,
Several types of sodium L-tyrosine, L-valine, L-aspartic acid, L-ascorbic acid, L-serine, and L-proline are used, and the vitamin components include biotin, choline chloride, and choline bitartrate. , folic acid, D
- Calcium pantothenate, isoinositol, nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride, sodium a-tocopherol phosphate, vitamin B, paraaminobenzoic acid, etc. are used, and as inorganic salt components, Potassium chloride, sodium bicarbonate, sodium chloride, anhydrous calcium chloride, anhydrous magnesium chloride. Anhydrous magnesium sulfate, anhydrous sodium dihydrogen phosphate, sodium hydrogen phosphate 7-hydrate fNaJPO44) IJ
I Sodium dihydrogen phosphate・L water (NaHtPO4・H
2O) Magnesium sulfate 7 water (MgSO, 7H, 0
At least one or more of potassium dihydrogen monophosphate, etc. is used, and ingredients other than the above include calcium butyrate, D-glucose, phenol red, sodium acetate, succinic acid, HEPES,
Albumin etc. are used. The method for producing the freeze-dried medium is as follows. In the first step, a predetermined amount of a field culture medium is dissolved in a predetermined amount of unzoned water to obtain a predetermined amount of a liquid medium. In the second step, a predetermined amount of the liquid medium is placed in a container with a predetermined capacity, and the container is placed in a freezing tank of a vacuum freeze dryer to freeze the liquid medium. In the third step, the container is connected to a vacuum freeze dryer and dried for a predetermined period of time. The freeze-dried medium obtained in the manner described above is used by being sealed in a medium-containing bag shown in FIG. The culture medium bag 1 is made of materials such as ethylene-vinyl alcohol, polyvinylidene chloride, polyamide, polyester,
Acrylonitrile (AN) and methyl acrylate (MA) in acrylonitrile loop sitadiene rubber (NBR)
A gas-impermeable flexible synthetic resin made of plasticizer-free soft polyvinyl chloride (product name: S-Medica V), (product name: Zeclon), etc., which are graft-copolymerized with It consists of a bag-like main body 2, a solvent injection tube 3 such as distilled water connected to the upper end of the main body 2, and a culture medium outlet 4 covered with a protector 8. A connecting needle 5 for connecting to a container containing a solvent such as distilled water is formed at the tip of the solvent injection tube 3, and a sterilizing filter 6 and a clamp 7 are arranged in the middle. The material of the sterilizing filter can be polyvinylidene 2-fluoride, polytetrafluoroethylene, cellulose ester, etc., and a filter with a pore size of 0.22μ can prevent the invasion of bacteria. Furthermore, the above-mentioned freeze-dried medium 9 is sealed inside the main body 2. The freeze-dried culture medium 9 may be sealed inside the main body 2 by sealing the bag-like main body 2 into a bag shape with a sheet or an extruded tube, or by sealing the freeze-dried culture medium 9 inside the main body 2. After forming, before connecting the oil medium injection tube 3 to the bag-like main body 2, insert the main body 2 from the vicinity of the connection part.
A culture medium may be introduced into the container. Alternatively, the freeze-dried medium may be dissolved in a predetermined amount of solvent to form a liquid medium, and this may be sealed in a medium bag. Before use, these medium-containing bags 1 are subjected to radiation sterilization, EOG sterilization, etc. to make them sterile. [Example] A method for producing Aitane Kaiyu freeze-dried medium will be described below. 10.4 g of powdered RPMI 1640 medium manufactured by Sigma and 2 g of sodium bicarbonate were dissolved in plain water over 10 minutes to prepare a 1β liquid medium. Next, 100 m12 of the liquid medium was added for 500 m! Place the container in a vacuum freeze dryer (manufactured by Tokyo Rikakiki,
The medium was placed in a freezing tank (type FD-1) and frozen for 15 minutes until the medium was frozen to the wall of the container. Furthermore, the container was connected to the vacuum line of a vacuum freeze dryer and dried for 22 hours at a vacuum degree of 76 + nmHg and a cooling temperature of -45°C. After drying, a porous solid lyophilized medium was obtained. When the same amounts of these freeze-dried media and the powdered PRMII 640 medium were collected and dissolved in the same amount of aqueous solution and the dissolution rates were visually compared, it was confirmed that the freeze-dried media dissolved more quickly in the aqueous solution. Ta. This is thought to be because the freeze-dried medium is a porous solid and thus has a larger surface area than the powdered medium. A method for adjusting a culture medium using the culture medium-containing bag of the present invention is as follows. A connecting needle 5 of a culture medium bag 1 is connected to the mouth of a plastic bottle 10 containing distilled water, and distilled water is injected into the main body 2 via the culture medium tube 3 due to the drop due to gravity. Bacteria existing in the distilled water are captured by the sterilizing filter 6 and there is no possibility of them entering the main body 2. After sealing and cutting the injection tube 3 near the upper end of the main body 2, the main body 2 is thoroughly stirred and the culture medium is dissolved in distilled water to prepare a predetermined culture medium. When using this culture medium, the protector 8 is broken to expose the culture medium outlet 4, and the attached communication needle 11 is connected to one end of the connection tube 12, and the other end of the connection tube 12 is connected to this. Connect the connecting needle 11 connected to one end to the medium inlet 14 (or 1
4a), and the medium is led out to the culture bag 13 (or concentrated culture bag 13a) through the communication tube 12 for culture. [Effects of the Invention] As explained above, (1) the freeze-dried medium of the present invention is easily dissolved in a solvent, and a liquid medium can be easily prepared. ■Medium bags containing freeze-dried media are easy to sterilize, long-term storage, and large-volume storage. It has excellent transportability. This is an excellent invention that has the following effects.
第1図は、培地入りバッグの概略図、第2図は、培地入
りバッグを調整する際の状態図、第3図は培地バッグ内
の培地を導出する際の概略図を示す。
図中、lは培地入りバッグ、2は本体。
3は溶媒注入チューブ、4は培地導出口、5は接続針、
6は除菌フィルター、7はクランプ、8はプロテクター
、9は凍結乾燥培地、11は連結針、12は連結チュー
ブ、13は培養バッグ、13aは濃縮培養バッグ、29
は凍結乾燥培地を溶解した液体培地、30は培地導入口
を示す。FIG. 1 is a schematic diagram of a bag containing a culture medium, FIG. 2 is a state diagram when adjusting the bag containing a culture medium, and FIG. 3 is a schematic diagram when drawing out the culture medium from the culture medium bag. In the figure, l is a bag containing the medium, and 2 is the main body. 3 is a solvent injection tube, 4 is a medium outlet, 5 is a connecting needle,
6 is a sterilization filter, 7 is a clamp, 8 is a protector, 9 is a freeze-dried medium, 11 is a connecting needle, 12 is a connecting tube, 13 is a culture bag, 13a is a concentrated culture bag, 29
30 indicates a liquid medium in which a freeze-dried medium has been dissolved, and a medium inlet.
Claims (2)
くとも1種類以上のビタミン成分と、少なくとも1種類
以上の無機塩類成分を含有する培地であって、凍結乾燥
処理されたことを特徴とする凍結乾燥培地。(1) Freeze-dried medium containing at least one or more types of amino acid components, at least one or more types of vitamin components, and at least one or more types of inorganic salt components, which is characterized by being subjected to freeze-drying treatment. Culture medium.
袋状本体の上端部の途中に除菌フィルターを配置した溶
媒注入チューブと培地導出口を装着し、前記本体の内部
には凍結乾燥培地が封入されてなることを特徴とする培
地入りバッグ。(2) A solvent injection tube with a sterilization filter and a medium outlet are attached to the upper end of the bag-like body made of a gas-impermeable flexible synthetic resin sheet. A medium-containing bag characterized by containing a dry medium.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1172721A JPH0339087A (en) | 1989-07-04 | 1989-07-04 | Lyophilized medium and bag containing same medium |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP1172721A JPH0339087A (en) | 1989-07-04 | 1989-07-04 | Lyophilized medium and bag containing same medium |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0339087A true JPH0339087A (en) | 1991-02-20 |
Family
ID=15947099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP1172721A Pending JPH0339087A (en) | 1989-07-04 | 1989-07-04 | Lyophilized medium and bag containing same medium |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0339087A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2767141A1 (en) * | 1997-08-08 | 1999-02-12 | Sanofi Elf | DEVICE FOR THE CULTURE OF LACTIC BACTERIA |
JP2005287425A (en) * | 2004-03-31 | 2005-10-20 | Koojin Bio Kk | Culture bag with culture medium bag |
JP2006223168A (en) * | 2005-02-17 | 2006-08-31 | Nikken Seibutsu Igaku Kenkyusho:Kk | Examination tool |
JP2010057390A (en) * | 2008-09-02 | 2010-03-18 | Nikken Seibutsu Igaku Kenkyusho:Kk | Test implement |
CN105624021A (en) * | 2015-02-16 | 2016-06-01 | 英特科学公司 | Microbial culture method using analysis bag filled with culture medium powders |
JP2017506895A (en) * | 2014-02-21 | 2017-03-16 | ライフ テクノロジーズ コーポレーション | System, method and apparatus for medium rehydration |
-
1989
- 1989-07-04 JP JP1172721A patent/JPH0339087A/en active Pending
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2767141A1 (en) * | 1997-08-08 | 1999-02-12 | Sanofi Elf | DEVICE FOR THE CULTURE OF LACTIC BACTERIA |
WO1999007825A1 (en) * | 1997-08-08 | 1999-02-18 | Sanofi Sante Nutrition Animale | Device for lactic bacteria culture |
JP2005287425A (en) * | 2004-03-31 | 2005-10-20 | Koojin Bio Kk | Culture bag with culture medium bag |
JP2006223168A (en) * | 2005-02-17 | 2006-08-31 | Nikken Seibutsu Igaku Kenkyusho:Kk | Examination tool |
JP2010057390A (en) * | 2008-09-02 | 2010-03-18 | Nikken Seibutsu Igaku Kenkyusho:Kk | Test implement |
JP2017506895A (en) * | 2014-02-21 | 2017-03-16 | ライフ テクノロジーズ コーポレーション | System, method and apparatus for medium rehydration |
US11407968B2 (en) | 2014-02-21 | 2022-08-09 | Life Technologies Corporation | Systems, methods, and apparatuses for media rehydration |
CN105624021A (en) * | 2015-02-16 | 2016-06-01 | 英特科学公司 | Microbial culture method using analysis bag filled with culture medium powders |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105969819B (en) | A kind of method of Production by Enzymes l-tyrosine | |
CN102453681B (en) | Protective agent for vacuum freeze drying of lactobacillus johnsonii, and application thereof | |
ES2221603T5 (en) | WATER SUPPLEMENTS CONTAINING LISINE FOR ANIMAL FEEDS, AND PROCEDURE FOR PREPARATION. | |
CN108251353A (en) | A kind of Human embryo in vitro culture liquid and culture systems | |
JPH0339087A (en) | Lyophilized medium and bag containing same medium | |
CN102302489A (en) | Preparation method of compound amino acid injection | |
CN109287622A (en) | A kind of marrow adoptive therapy the companion colorectal cancer of HIV infection and the tissue preserration liquid of decompensation small hepatocellular carcinoma in patients with cirrhosis | |
US20050175643A1 (en) | Carbon dioxide compositions for external use and process for producing the same | |
JPH0458445B2 (en) | ||
CN104313105B (en) | The method that a kind of utilization threonine fermentation liquid and waste liquor prepare 65% threonine | |
CN101019822A (en) | Separately packed fatty milk, amino acid and glucose injection composition and the prepn process | |
CN106065399A (en) | A kind of bacteriophage preserves protective agent and its preparation method and application | |
WO1994016688A1 (en) | Nutritive composition | |
AU2019369917C1 (en) | Use of cysteine or salt thereof for cryoprotecting lactic acid bacteria | |
CN108078931B (en) | A kind of bendamustine hydrochloride freeze-dried powder needle and preparation method thereof | |
CN1475159A (en) | Fermentation type sea cucumbus nutrient product and its preparation method | |
CN104694614A (en) | Novel extraction process of L-tryptophan | |
CN1164344A (en) | Marine yeast feed and its producing method and use | |
CN110938138B (en) | Method for simultaneously extracting phycocyanin and glycerol glucoside | |
FR2753099A1 (en) | Solutions for renal dialysis | |
RU2115657C1 (en) | Aqua chelate, method of preparing aqua chelate, method of modulating cell culture characteristics, tissue cultures, single-cell or multi-cell organism cultures, and transport system for transferring metal and organic ligands on cell membrane | |
RU2105562C1 (en) | Method of preparing base-bacillus subtilis bacterial preparation | |
CN105248837A (en) | Chlorella active polypeptide powder preparing method | |
CN101884621B (en) | Method for preparing salinomycin particle premix | |
RU2036967C1 (en) | Method of preparing nutrient medium for cultivating bifidobacteria |